We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Development and validation of a clinical nomogram to predict prostatic inflammation in men with lower urinary tract symptoms

    Background

    Prostatic inflammation is an important etiological component of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS)....

    Stavros Gravas, Cosimo De Nunzio, ... Mauro Gacci in Prostate Cancer and Prostatic Diseases
    Article Open access 06 July 2024
  2. Homoharringtonine may help improve the outcomes of venetoclax and azacitidine in AML1-ETO positive acute myeloid leukemia

    Purpose

    T(8;21)(q22;q22.1)/AML1-ETO positive acute myeloid leukemia (AE-AML) is sensitive to conventional chemotherapy with a favorable prognosis....

    Zhao Yin, Zurong Yao, ... Guopan Yu in Journal of Cancer Research and Clinical Oncology
    Article Open access 06 July 2024
  3. UBQLN4 promotes the proliferation and invasion of non-small cell lung cancer cell by regulating PI3K/AKT pathway

    Background

    Ubiquilin-4 (UBQLN4), a member of the ubiquilin family, has received limited attention in cancer research to date. Here, we investigated...

    Li He, Heng Chen, ... Rui Zou in Journal of Cancer Research and Clinical Oncology
    Article Open access 06 July 2024
  4. Machine learning-based decision support model for selecting intra-arterial therapies for unresectable hepatocellular carcinoma: A national real-world evidence-based study

    Importance

    Intra-arterial therapies(IATs) are promising options for unresectable hepatocellular carcinoma(HCC). Stratifying the prognostic risk before...

    Chao An, Ran Wei, ... Jianjun Han in British Journal of Cancer
    Article 06 July 2024
  5. Gastric microbiome signature for predicting metachronous recurrence after endoscopic resection of gastric neoplasm

    Background

    Changes in gastric microbiome are associated with gastric carcinogenesis. Studies on the association between gastric mucosa-associated...

    Ho-Kyoung Lee, Cheol Min Shin, ... Dong Ho Lee in Gastric Cancer
    Article 06 July 2024
  6. Lack of cellular prion protein causes Amyloid β accumulation, increased extracellular vesicle abundance, and changes to exosome biogenesis proteins

    Alzheimer's disease (AD) progression is closely linked to the propagation of pathological Amyloid β (Aβ), a process increasingly understood to...

    Lovisa Johansson, Juan F. Reyes, ... Martin Hallbeck in Molecular and Cellular Biochemistry
    Article Open access 06 July 2024
  7. PARP inhibition with rucaparib alone followed by combination with atezolizumab: Phase Ib COUPLET clinical study in advanced gynaecological and triple-negative breast cancers

    Background

    Combining PARP inhibitors (PARPis) with immune checkpoint inhibitors may improve clinical outcomes in selected cancers. We evaluated...

    Rebecca Kristeleit, Alexandra Leary, ... Linda Mileshkin in British Journal of Cancer
    Article Open access 06 July 2024
  8. Exploring the causal association between uric acid and lung cancer in east Asian and European populations: a mendelian randomization study

    Background

    Lung cancer still ranks first in the mortality rate of cancer. Uric acid is a product of purine metabolism in humans. Its presence in the...

    ** Lin, Linxiang Zhang, ... Jihuang Wang in BMC Cancer
    Article Open access 05 July 2024
  9. Participants’ perspectives of being recruited into a randomised trial of a weight loss intervention before colorectal cancer surgery: a qualitative interview study

    Background

    The period between cancer diagnosis and surgery presents an opportunity for trials to assess the feasibility of behaviour change...

    Amelia Talbot, Susan A Jebb, ... Dimitrios A Koutoukidis in BMC Cancer
    Article Open access 05 July 2024
  10. HIV-protease inhibitors potentiate the activity of carfilzomib in triple-negative breast cancer

    Background

    Resistance to chemotherapy is a major problem in the treatment of patients with triple-negative breast cancer (TNBC). Preclinical data...

    Andrej Besse, Lenka Sedlarikova, ... Lenka Besse in British Journal of Cancer
    Article Open access 05 July 2024
  11. Clinical outcome predictors for metastatic renal cell carcinoma: a retrospective multicenter real-life case series

    Over the last decades, the therapeutic armamentarium of metastatic renal cell carcinoma (mRCC) has been revolutionized by the advent of...

    Mimma Rizzo, Gaetano Pezzicoli, ... Silvana Quaglini in BMC Cancer
    Article Open access 05 July 2024
  12. Is the Homologous Recombination Repair Mutation Defined by a 15-Gene Panel Associated with the Prognosis of Epithelial Ovarian Cancer?

    Background

    There is no consensus regarding the specific genes included in the homologous recombination repair (HRR) gene panel for identifying the HRR...

    Yi Liu, **aojun Chen, ... Ying Zhou in Molecular Diagnosis & Therapy
    Article 05 July 2024
  13. Hematopoietic stem cell transplantation for DLBCL: a report from the European Society for Blood and Marrow Transplantation on more than 40,000 patients over 32 years

    Autologous(auto-) and allogeneic(allo-) hematopoietic stem cell transplantation (HSCT) are key treatments for relapsed/refractory diffuse large...

    Philipp Berning, Mathilde Fekom, ... Norbert Schmitz in Blood Cancer Journal
    Article Open access 05 July 2024
  14. ASS1: Guardian of the genome

    Gabrielle Brewer in Nature Reviews Cancer
    Article 05 July 2024
  15. Towards targeting the breast cancer immune microenvironment

    The tumour immune microenvironment is shaped by the crosstalk between cancer cells, immune cells, fibroblasts, endothelial cells and other stromal...

    Michael A. Harris, Peter Savas, ... Sherene Loi in Nature Reviews Cancer
    Article 05 July 2024
Did you find what you were looking for? Share feedback.